Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1997 Nov;4(6):789–791. doi: 10.1128/cdli.4.6.789-791.1997

Altered expression of Fc gammaRIII (CD16) on polymorphonuclear neutrophils from individuals with human immunodeficiency virus type 1 disease and pulmonary tuberculosis.

S Meddows-Taylor 1, D J Martin 1, C T Tiemessen 1
PMCID: PMC170661  PMID: 9384310

Abstract

Fc gammaRIII (CD16) expression on the surfaces of polymorphonuclear neutrophils was significantly reduced in human immunodeficiency virus type 1-seropositive patients with pulmonary tuberculosis compared to that in individuals with either disease alone or in healthy blood donors. This downregulation of Fc gammaRIII may contribute to the enhanced susceptibility of coinfected individuals to opportunistic infections.

Full Text

The Full Text of this article is available as a PDF (138.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boros P., Gardos E., Bekesi G. J., Unkeless J. C. Change in expression of Fc gamma RIII (CD16) on neutrophils from human immunodeficiency virus-infected individuals. Clin Immunol Immunopathol. 1990 Feb;54(2):281–289. doi: 10.1016/0090-1229(90)90089-9. [DOI] [PubMed] [Google Scholar]
  2. Chave J. P., Bille J., Glauser M. P., Francioli P. Diagnosis of pulmonary infections in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis. 1989 Feb;8(2):123–126. doi: 10.1007/BF01963894. [DOI] [PubMed] [Google Scholar]
  3. Estevez M. E., Ballart I. J., Diez R. A., Planes N., Scaglione C., Sen L. Early defect of phagocytic cell function in subjects at risk for acquired immunodeficiency syndrome. Scand J Immunol. 1986 Aug;24(2):215–221. doi: 10.1111/j.1365-3083.1986.tb02088.x. [DOI] [PubMed] [Google Scholar]
  4. Fanger M. W., Shen L., Graziano R. F., Guyre P. M. Cytotoxicity mediated by human Fc receptors for IgG. Immunol Today. 1989 Mar;10(3):92–99. doi: 10.1016/0167-5699(89)90234-X. [DOI] [PubMed] [Google Scholar]
  5. Fleit H. B., Wright S. D., Durie C. J., Valinsky J. E., Unkeless J. C. Ontogeny of Fc receptors and complement receptor (CR3) during human myeloid differentiation. J Clin Invest. 1984 Feb;73(2):516–525. doi: 10.1172/JCI111238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Galon J., Gauchat J. F., Mazières N., Spagnoli R., Storkus W., Lötze M., Bonnefoy J. Y., Fridman W. H., Sautès C. Soluble Fcgamma receptor type III (FcgammaRIII, CD16) triggers cell activation through interaction with complement receptors. J Immunol. 1996 Aug 1;157(3):1184–1192. [PubMed] [Google Scholar]
  7. Huizinga T. W., Dolman K. M., van der Linden N. J., Kleijer M., Nuijens J. H., von dem Borne A. E., Roos D. Phosphatidylinositol-linked FcRIII mediates exocytosis of neutrophil granule proteins, but does not mediate initiation of the respiratory burst. J Immunol. 1990 Feb 15;144(4):1432–1437. [PubMed] [Google Scholar]
  8. Huizinga T. W., Kerst M., Nuyens J. H., Vlug A., von dem Borne A. E., Roos D., Tetteroo P. A. Binding characteristics of dimeric IgG subclass complexes to human neutrophils. J Immunol. 1989 Apr 1;142(7):2359–2364. [PubMed] [Google Scholar]
  9. Huizinga T. W., de Haas M., Kleijer M., Nuijens J. H., Roos D., von dem Borne A. E. Soluble Fc gamma receptor III in human plasma originates from release by neutrophils. J Clin Invest. 1990 Aug;86(2):416–423. doi: 10.1172/JCI114727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Huizinga T. W., van der Schoot C. E., Jost C., Klaassen R., Kleijer M., von dem Borne A. E., Roos D., Tetteroo P. A. The PI-linked receptor FcRIII is released on stimulation of neutrophils. Nature. 1988 Jun 16;333(6174):667–669. doi: 10.1038/333667a0. [DOI] [PubMed] [Google Scholar]
  11. Jones G. S., Amirault H. J., Andersen B. R. Killing of Mycobacterium tuberculosis by neutrophils: a nonoxidative process. J Infect Dis. 1990 Sep;162(3):700–704. doi: 10.1093/infdis/162.3.700. [DOI] [PubMed] [Google Scholar]
  12. Khayat D., Geffrier C., Yoon S., Scigliano E., Soubrane C., Weil M., Unkeless J. C., Jacquillat C. Soluble circulating Fc gamma receptors in human serum. A new ELISA assay for specific and quantitative detection. J Immunol Methods. 1987 Jun 26;100(1-2):235–241. doi: 10.1016/0022-1759(87)90194-3. [DOI] [PubMed] [Google Scholar]
  13. Khayat D., Soubrane C., Andrieu J. M., Visonneau S., Eme D., Tourani J. M., Beldjord K., Weil M., Fernandez E., Jacquillat C. Changes of soluble CD16 levels in serum of HIV-infected patients: correlation with clinical and biologic prognostic factors. J Infect Dis. 1990 Mar;161(3):430–435. doi: 10.1093/infdis/161.3.430. [DOI] [PubMed] [Google Scholar]
  14. Kleinhenz M. E., Ellner J. J., Spagnuolo P. J., Daniel T. M. Suppression of lymphocyte responses by tuberculous plasma and mycobacterial arabinogalactan. Monocyte dependence and indomethacin reversibility. J Clin Invest. 1981 Jul;68(1):153–162. doi: 10.1172/JCI110231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kurosaki T., Ravetch J. V. A single amino acid in the glycosyl phosphatidylinositol attachment domain determines the membrane topology of Fc gamma RIII. Nature. 1989 Dec 14;342(6251):805–807. doi: 10.1038/342805a0. [DOI] [PubMed] [Google Scholar]
  16. Lanier L. L., Cwirla S., Yu G., Testi R., Phillips J. H. Membrane anchoring of a human IgG Fc receptor (CD16) determined by a single amino acid. Science. 1989 Dec 22;246(4937):1611–1613. doi: 10.1126/science.2531919. [DOI] [PubMed] [Google Scholar]
  17. Lanier L. L., Phillips J. H., Testi R. Membrane anchoring and spontaneous release of CD16 (FcR III) by natural killer cells and granulocytes. Eur J Immunol. 1989 Apr;19(4):775–778. doi: 10.1002/eji.1830190431. [DOI] [PubMed] [Google Scholar]
  18. McDougal J. S., Hubbard M., Nicholson J. K., Jones B. M., Holman R. C., Roberts J., Fishbein D. B., Jaffe H. W., Kaplan J. E., Spira T. J. Immune complexes in the acquired immunodeficiency syndrome (AIDS): relationship to disease manifestation, risk group, and immunologic defect. J Clin Immunol. 1985 Mar;5(2):130–138. doi: 10.1007/BF00915011. [DOI] [PubMed] [Google Scholar]
  19. Palmer S., Hamblin A. S. Increased CD11/CD18 expression on the peripheral blood leucocytes of patients with HIV disease: relationship to disease severity. Clin Exp Immunol. 1993 Sep;93(3):344–349. doi: 10.1111/j.1365-2249.1993.tb08183.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sandborg R. R., Smolen J. E. Early biochemical events in leukocyte activation. Lab Invest. 1988 Sep;59(3):300–320. [PubMed] [Google Scholar]
  21. Scallon B. J., Scigliano E., Freedman V. H., Miedel M. C., Pan Y. C., Unkeless J. C., Kochan J. P. A human immunoglobulin G receptor exists in both polypeptide-anchored and phosphatidylinositol-glycan-anchored forms. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5079–5083. doi: 10.1073/pnas.86.13.5079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Schuchat A., Broome C. V., Hightower A., Costa S. J., Parkin W. Use of surveillance for invasive pneumococcal disease to estimate the size of the immunosuppressed HIV-infected population. JAMA. 1991 Jun 26;265(24):3275–3279. [PubMed] [Google Scholar]
  23. Selvaraj P., Carpén O., Hibbs M. L., Springer T. A. Natural killer cell and granulocyte Fc gamma receptor III (CD16) differ in membrane anchor and signal transduction. J Immunol. 1989 Nov 15;143(10):3283–3288. [PubMed] [Google Scholar]
  24. Selvaraj P., Rosse W. F., Silber R., Springer T. A. The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal haemoglobinuria. Nature. 1988 Jun 9;333(6173):565–567. doi: 10.1038/333565a0. [DOI] [PubMed] [Google Scholar]
  25. Wenisch C., Parschalk B., Zedwitz-Liebenstein K., Graninger W., Rieger A. Dysregulation of the polymorphonuclear leukocyte--Candida spp. interaction in HIV-positive patients. AIDS. 1996 Aug;10(9):983–987. doi: 10.1097/00002030-199610090-00008. [DOI] [PubMed] [Google Scholar]
  26. Whalen C., Horsburgh C. R., Hom D., Lahart C., Simberkoff M., Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med. 1995 Jan;151(1):129–135. doi: 10.1164/ajrccm.151.1.7812542. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES